Serum Institute of India Current Affairs, GK & News
India’s first indigenously developed qHPV against cervical cancer
Recently Serum Institute of India (SII) and Department of Biotechnology (DBT) launched indigenously developed quadrivalent Human Papilloma Virus (HPV) vaccine for prevention of cervical cancer. Highlights The Drug Controller General of India (DCGI) last month granted market authorization to Serum Institute of India (SII) for the production of this indigenously developed vaccine against cervical cancer. ..
Month: Current Affairs - August, 2022
Category: Science & Technology Current Affairs
Topics: CERVAVAC • Cervical cancer • Department of Biotechnology • qHPV • quadrivalent Human Papilloma Virus • Serum Institute of India
IndRa: Cost of vaccinating India’s population above 18 years 0.36% of GDP
The India Ratings and Research (Ind-Ra) recently said the estimated cost to vaccinate all the Indians of age 18 years will be Rs 67,193 crores. This is 0.36% of the GDP of the country. Key Findings The GoI recently announced the Liberalised and Accelerated Phase 3 strategy of COVID-19 vaccine. According to the new strategy, ..
Month: Current Affairs - April, 2021
Category: Reports & Indexes Current Affairs
Topics: Bharat Biotech • COVAXIN • COVID-19 vaccine • Covishield • Ind-Ra • Serum Institute of India
PM Takes First Dose of COVID-19 Vaccine
The Prime Minister of India, Narendra Modi, takes first dose of COVID-19 vaccine on March 1, 2021 at AIIMS, New Delhi. After vaccination, he appealed to those people who are eligible to get their vaccination done. Covid-19 Vaccination in India The national vaccination programme to for the virus called “SARS-CoV-2” which has caused ongoing Covid-19 ..
Month: Current Affairs - March, 2021
Category: India Nation & States Current Affairs
Topics: COVAXIN Vaccine • COVID-19 • Global Covid-19 Vaccination Plan • Narendra Modi • Serum Institute of India
COVID-19 Vaccination Phase 2 to begin from March 1
The Union Government has announced that the second phase of COVID-19 vaccination will begin from March 1, 2021. Highlights Under the second phase of covid-19 vaccination, people aged above 60 years will get vaccinated. Further, as per the guidelines, those aged above 45 years and are having comorbidities (that means presence of one or more ..
Month: Current Affairs - February, 2021
Category: India Nation & States Current Affairs
Topics: COVID-19 • COVID-19 vaccine • Global Covid-19 Vaccination Plan • Phase II of covid vaccination • Serum Institute of India
SII’s Covishield gets emergency-use nod from DGCI
The Subject Expert committee that is advising the Drug Controller General of India (DCGI) recommended restricted Emergency Use Authorisation for COVISHIELD. COVISHIELD vaccine was developed by Serum Institute of India. Who manufactures COVISHIELD? The COVISHIELD the vaccine is developed by the University of Oxford and the British Pharmaceutical major Astra Zeneca. In India, the vaccine ..
Month: Current Affairs - January, 2021
Category: India Nation & States Current Affairs
Topics: AstraZeneca • Bharat Biotech Limited • Clinical trials • COVAXIN • COVAXIN Vaccine • COVID-19 vaccine • Covishield • Director controller General of India • Serum Institute of India
Pneumosil: India’s First Pneumonia Vaccine
The Serum Institute of India recently unveiled the first indigenously developed Pneumococcal Vaccine called Pneumosil. The vaccine was launched by the Union Health Minister Harsh Vardhan. About the Vaccine Pneumosil was developed through collaboration with Bill and Melinda Gates Foundation and PATH organization. It has been approved by the Drugs Controller General of India. The ..
Month: Current Affairs - December, 2020
Category: Science & Technology Current Affairs
Topics: GAVI • indigenous vaccine • PCV vaccine • Pneumonia • Pneumonia Deaths • pneumosil • Serum Institute of India • WHO